Biloban

Manufacturer

Laboratórios Atral, S.A. – Portugal

Applicant company

TV Pharmaceutical Trade Promotion and Investment Co., Ltd.

Active ingredient

Ginkgo biloba leaf extract (Extractum Folii Ginkgo siccus)

Content

80 mg

Shelf life

24 months

Dosage Form

Film-coated tablets

Package

Box of 2 blisters x 15 tablets; Box of 4 blisters x 15 tablets

Visa Number

560200180400

Issuing Date

December 7, 2024

Expiration Date

December 7, 2029

Indication

Biloban is indicated for the treatment of:
- Attention and memory impairment in elderly patients.
- Selected visual disorders (diabetic retinopathy) and ear, nose, and throat (ENT) disorders (vertigo, tinnitus, hypacusis), as well as neurosensory circulatory disorders suspected to be of ischemic origin.

Dosage

The recommended daily dose is 3 tablets (equivalent to 240 mg of Ginkgo biloba leaf extract), administered in 3 divided doses.